TITLE

INTERNAL MEDICINE

AUTHOR(S)
Naunton, Mark
PUB. DATE
December 2010
SOURCE
Journal of Pharmacy Practice & Research;Dec2010, Vol. 40 Issue 4, p327
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses several reports regarding internal medicine research, including one investigating the affect of timing of antihypertensives on cardiovascular events, one on the possible relationship between the use of a proton pump inhibitors (PPIs) with clopidogrel and cardiovascular risk, and one investigating the role of the long-acting anticholinergic, tiotropium, in the management of uncontrolled asthma.
ACCESSION #
57408687

 

Related Articles

  • Antihypertensives in octogenarians. Mancia, Giuseppe // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/14/2012, Vol. 344 Issue 7839, p8 

    The author reflects on the Hypertension in the Very Elderly Trial (HYVET), one of the most key trials in the history of antihypertensive treatment. He discusses an open label treatment extension of the original HYVET study by N. S. Beckett and colleagues which concludes that treatment of...

  • Systematic review of anticholinergic risk scales in older adults. Response to letter of the editor. Durán, Carlos; Azermai, Majda; Stichele, Robert // European Journal of Clinical Pharmacology;Sep2013, Vol. 69 Issue 9, p1731 

    A letter to the editor is submitted in response to the article "Cognitive Effects of Reducing Anticholinergic Drug Burden in a Frail Elderly Population: A Randomized Controlled Trial" by H. Kersten et al.

  • Benefits of hypertension treatment apparent even in the very old.  // Geriatrics;Jun99, Vol. 54 Issue 6, p47 

    Presents an abstract of the article `Antihypertensive Drugs in Very Old People: A Subgroup Meta-Analysis of Randomised Controlled Trials,' by F. Gueyffier, C. Bulpitt et al, which appeared in the March 6, 1999 issue of `The Lancet.'

  • Aspirin/clopidogrel/ibuprofen/proton pump inhibitor interaction.  // Reactions Weekly;12/1/2012, Issue 1430, p8 

    The article describes the case of a 51-year-old patient who experienced low responsiveness to dual antiplatelet therapy while receiving treatment with clopidogrel, proton pump inhibitor, aspirin and ibuprofen.

  • FDA Actions. Elliott, William T. // Infectious Disease Alert;May2010 Supplement, p2 

    The article presents an update on actions taken by the U.S. Food and Drug Administration (FDA) as of May 2010, including the issuance of a warning to health care providers that a part of the population did not metabolize the antiplatelet drug clopidogrel and the approval of a request from Takeda...

  • PPIs and Clopidogrel: Do We Have to Worry? Kuritzky, Louis // OB/GYN Clinical Alert;Dec2009, Vol. 26 Issue 8, p23 

    The article reports on the pharmacological relation between proton pump inhibitor (PPI) and clopidogrel in the U.S. It mentions that the antiplatelet effect of clopidogrel depends on its conversion and activation through the 2C19 pathway of the P450 system where the blockade of this pathway...

  • Safety of proton pump inhibitors. Elliott, William T. // Critical Care Alert;Nov2010 Pharmacology, p1 

    The article reports on the study which revealed the possibility that proton pump inhibitors (PPI) may be related with an increased risk for cardiovascular (CV) diseases.

  • Interaction between clopidogrel and proton pump inhibitors: Literature to clinical practice. Hadi, Muhammad Abdul; Tan Chong Lip // Australasian Medical Journal;Jun2011, Vol. 4 Issue 6, p281 

    A letter to the editor is presented regarding the interaction between proton pump inhibitors (PPI) and clopidogrel.

  • Coprescription of clopidogrel and proton pump inhibitors. Small, Gary R.; Chow, Benjamin J. W.; So, Derek Y. F. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/21/2011, Vol. 342 Issue 7807, p1096 

    The authors reflect on the safety and efficacy of the coprescription of clopidogrel and proton pump inhibitors. The authors state that the said coprescription is usually administered after an acute coronary event or percutaneous coronary intervention to lessen reinfarction and avoid in-stent...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics